Law360, New York (August 10, 2004, 12:00 AM EDT) -- Australian biotech company Benitec Ltd. has settled its U.S. patent infringement case against rival Ambion over gene silencing technologies.
As part of the settlement, Benitec has issued to Ambion a world-wide non-exclusive license to make and sell DNA-directed RNAi based products, according to Benitec.
The settlement resolves all claims and counter claims that began when Benitec filed its lawsuit in March in the U.S. District Court for the District of Delaware. Financial details of the settlement and licensing agreement were not available.
Benitec claims it was...
Benitec Settles Patent Dispute With Ambion
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login
